Public pension funds have major stakes in American firms moving overseas to cut their tax bills. But they are saying little about the strategy.» Read More
Becton, Dickinson& Co. fell$. 56 or. 5 percent, to $116.97. Covidien fell$. 76 or. 9 percent, to $88.26. PerkinElmer fell$. 23 or. 5 percent, to $44.89.
Becton, Dickinson& Co. fell$. 29 or. 2 percent, to $117.24. Covidien fell$. 39 or. 4 percent, to $88.63. PerkinElmer fell$. 05 or. 1 percent, to $45.08.
Becton, Dickinson& Co. fell$. 11 or. 1 percent, to $117.53. Covidien rose$. 23 or. 3 percent, to $89.02. PerkinElmer fell$. 03 or. 1 percent, to $45.12.
Becton, Dickinson& Co. fell$. 33 or. 3 percent, to $117.31. Covidien rose$. 32 or. 4 percent, to $89.11. PerkinElmer fell$. 09 or. 2 percent, to $45.06.
Becton, Dickinson& Co. fell$. 58 or. 5 percent, to $117.64. Covidien rose$. 35 or. 4 percent, to $88.79. PerkinElmer fell$. 45 or 1.0 percent, to $45.15.
Becton, Dickinson& Co. fell$. 64 or. 5 percent, to $117.58. Covidien rose$. 17 or. 2 percent, to $88.61. PerkinElmer fell$. 44 or 1.0 percent, to $45.16.
Becton, Dickinson& Co. fell$. 77 or. 7 percent, to $117.45. Covidien plc fell$. 30 or. 3 percent, to $88.14. PerkinElmer fell$. 35 or. 8 percent, to $45.25.
Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.
Aug 19- Medtronic Inc reported the strongest quarterly U.S. sales growth for its medical devices in five years and said it was committed to completing the acquisition of Irish-domiciled Covidien Plc by the end of the year or early 2015.. Minneapolis- based Medtronic also confirmed its full-year profit and revenue outlook on Tuesday.
Diversified U.S. manufacturer 3 M Co and medical equipment makers CareFusion Corp and C.R. Bard Inc are among the companies exploring a potential deal for ConvaTec, the people said. CareFusion, with a market capitalization of $9 billion, and C.R. Bard, with $11.2 billion, would both be able to achieve an inversion if they use their own stock to pay for ConvaTec.
Aug 14- Top U.S. hedge fund managers did some shopping for shares of discount retailer Dollar General Corp and drug store operator Walgreen Co in the second quarter.
Daniel Loeb's Third Point added 1 million shares of Dollar General, raising his stake by 33 percent, while Blue Ridge Capital, founded by Tiger Cub John Griffin, nearly doubled its stake in Walgreen when it bought 2.8 million shares.
BOSTON, Aug 13- Harvard Management Co, which oversees the Ivy League school's $32.7 billion endowment, took a new position in surgical device maker Covidien Plc during the second quarter before news of a planned takeover helped push the stock price higher, a regulatory filing shows.
NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.
DUBLIN, July 30- Ireland is in the firing line from Washington again for luring U.S. companies to its shores for tax benefits, but despite contrite noises coming from Dublin, it has too much to lose to discourage U.S. firms bent on shifting their tax domiciles.
DUBLIN, July 25- Ireland defended its tax regime on Friday against criticism from U.S. Singling out Ireland for criticism, Obama on Thursday hammered U.S. companies that avoid federal taxes by shifting their tax domiciles overseas and called on Congress to pass a bill to curb such deals, known as "inversions".
There's been "nothing, nothing, nothing, nothing" from Obama on corporate tax cuts in five years, Grover Norquist tells CNBC.
President Barack Obama’s push to deter U.S. firms from buying foreign companies for tax purposes will make several deals less attractive.
Even as traders monitor the world's hot spots, corporate earnings news could be a positive for stocks in the week ahead.
July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.